Hugh Cleland, CFA Trillium Therapeutics Inc TRIL-T WATCH Mar 31, 2008

Fascinated by the technology, they’re taking 2 off patent drugs and combining them to use in therapy for stroke victims. Has a lot of potential. Still has some huge upside.

Hugh Cleland, CFA

Owned

Unlock Rating

$0.240

Stock price when the opinion was issued

Consumer Products

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

HOLD

(Market Call Minute.) Volatile stock and you can hold it if it hangs in there but be careful.

COMMENT

Pfizer bought it today, and TRIL shares tripled from $6 to $18 in the blink of an eye. That's why he always advises investing in small drug companies; sometimes they pan out.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Hugh Cleland, CFA Trillium Therapeutics Inc TRIL-T WATCH Mar 31, 2008

You might be interested:

Trillium Therapeutics Inc(TRIL-T)

Trillium Therapeutics Inc(TRIL-T)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Michael Sprung

Larry Berman CFA, CMT, CTA

Stockchase Insights

Jim Cramer - Mad Money

Greg Newman